Jade Biosciences annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Jade Biosciences Depreciation & Amortization Growth & History (JBIO)
Jade Biosciences's depreciation and amortization was $26,000 for fiscal 2025.
View full Jade Biosciences company overviewJade Biosciences annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $26,000 | −$256,000 | −90.78% |
| 2024 | 2024-12-31 | $282,000 | $186,000 | +193.75% |
| 2023 | 2023-12-31 | $96,000 | $28,000 | +41.18% |
| 2022 | 2022-12-31 | $68,000 | $53,000 | +353.33% |
| 2021 | 2021-12-31 | $15,000 | $14,000 | +1400.00% |
| 2020 | 2020-12-31 | $1,000 | — | — |
Jade Biosciences quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9,000 | $8,000 | +800.00% |
| Q1 2026 | 2026-03-31 | $9,000 | $5,000 | +125.00% |
| Q4 2025 | 2025-12-31 | $9,000 | — | — |
| Q3 2025 | 2025-09-30 | $12,000 | −$206,000 | −94.50% |
| Q2 2025 | 2025-06-30 | $1,000 | −$27,000 | −96.43% |
| Q1 2025 | 2025-03-31 | $4,000 | −$24,000 | −85.71% |
| Q3 2024 | 2024-09-30 | $218,000 | $193,000 | +772.00% |
| Q2 2024 | 2024-06-30 | $28,000 | $6,000 | +27.27% |
| Q1 2024 | 2024-03-31 | $28,000 | $7,000 | +33.33% |
| Q3 2023 | 2023-09-30 | $25,000 | $5,000 | +25.00% |
| Q2 2023 | 2023-06-30 | $22,000 | $5,000 | +29.41% |
| Q1 2023 | 2023-03-31 | $21,000 | $10,000 | +90.91% |
| Q3 2022 | 2022-09-30 | $20,000 | $17,000 | +566.67% |
| Q2 2022 | 2022-06-30 | $17,000 | $15,000 | +750.00% |
| Q1 2022 | 2022-03-31 | $11,000 | $9,000 | +450.00% |
| Q3 2021 | 2021-09-30 | $3,000 | — | — |
| Q2 2021 | 2021-06-30 | $2,000 | — | — |
| Q1 2021 | 2021-03-31 | $2,000 | — | — |
Jade Biosciences depreciation and amortization trends
Over the last five fiscal years, Jade Biosciences's depreciation and amortization increased from $1,000 to $26,000, a change of $25,000. The latest reported quarter, Q2 2026, shows $9,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jade Biosciences source filings ↗